Edition:
United States

Profile: Sun Pharmaceutical Industries Ltd (SUN.NS)

SUN.NS on National Stock Exchange of India

614.10INR
23 May 2017
Change (% chg)

-- (--)
Prev Close
Rs614.10
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
3,147,841
52-wk High
Rs854.95
52-wk Low
Rs571.90

Sun Pharmaceutical Industries Limited is a pharmaceuticals company. The Company's business segments include US Business, Indian Branded Generics Business, Emerging Markets, Global Consumer Healthcare Business and Active Pharmaceutical Ingredients (API). Its Rest of World segment includes Western Europe, Canada, Australia, New Zealand and other markets. The Company offers its products to therapy areas, such as cardiology, neuro-psychiatry, gastroenterology, anti-infective, diabetology and dermatology. The Company's products include AB PHYLLINE, ABZORB DUSTING POWDER, ACAMPROL, ACOSTIN 3 MIU, ACOSTIN FORTE and AB PHYLLINE SR 200. Its manufacturing units are situated in India, the United States and Brazil, among others. Its units produce generics, branded generics, specialty products, over-the-counter (OTC) products, anti-retroviral (ARVs) and APIs. They also produce intermediates in a range of dosage forms, including tablets, capsules, injectables, ointments, creams and liquids.

Company Address

Sun Pharmaceutical Industries Ltd

Acme Plaza
Andheri Kurla Road, Andheri East
MUMBAI     400059
P: +91265.5515500
F: +91265.2354897

Company Web Links